Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / HZNP - Horizon Therapeutics submits regulatory filing for approval of Uplizna in Brazil

HZNP - Horizon Therapeutics submits regulatory filing for approval of Uplizna in Brazil

Horizon Therapeutics Public Limited Company
Horizon Therapeutics (NASDAQ:HZNP) on Wednesday said it had submitted a filing to Brazilian health regulator Anvisa for approval of its Uplizna medicine for the treatment of anti-aquaporin-4 immunoglobulin G seropositive neuromyelitis optica spectrum disorder (NMOSD). NMOSD occurs when the body's immune system reacts against its own cells in the central nervous system, mainly in the optic nerves and spinal cord, and sometimes in the brain. Uplizna is already approved by the U.S. FDA, and has also received approvals in Japan and from the European Commission. HZNP stock +0.5% to $81.70 in morning trading.

For further details see:

Horizon Therapeutics submits regulatory filing for approval of Uplizna in Brazil
Stock Information
Company Name: Horizon Therapeutics Public Limited Company
Stock Symbol: HZNP
Market: NASDAQ
Website: horizontherapeutics.com
Menu
HZNP HZNP Quote HZNP Short HZNP News HZNP Articles HZNP Message Board
Get HZNP Alerts

News, Short Squeeze, Breakout and More Instantly...